AlconMEX:ALC N 73 OCF Yield % is 7.08 as of Jun. 25, 2026, which is 115% above its 10-year median of 3.30. GuruFocus rates MEX:ALC N with a GF Score™ of 73/100 and a GF Value™ of MXN1,750.95 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Alcon ranks better than 76.76% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Alcon's OCF Yield % or its related term are showing as below:
MEX:ALC N'
s OCF Yield % Range Over the Past 10 Years
Min: 0.1 Med: 3.3 Max: 7.64
Current: 7.08
During the past 10 years, the highest OCF Yield % of Alcon was 7.64%. The lowest was 0.10%. And the median was 3.30%.
MEX:ALC N's OCF Yield % is ranked better than 76.76% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.76
vs MEX:ALC N: 7.08
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Alcon OCF Yield % Related Terms
Alcon OCF Yield % Historical Data
* Premium members only.
The historical data trend for Alcon's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ALC N vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Alcon's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcon OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alcon's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Alcon's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcon (MEX:ALC N) has a OCF Yield % of 7.08 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Alcon and its competitors. This is 115% above median its historical median of 3.30. Over the past decade, Alcon's OCF Yield % has ranged from 0.10 to 7.64. According to the industry distribution chart, Alcon ranks #198 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 23.2%.
Is Alcon's OCF Yield % too high?
Alcon's current OCF Yield % of 7.08 is 115% above median its 10-year median of 3.30. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 7.64. The Medical Devices & Instruments industry median OCF Yield % is 1.76. Alcon's value of 7.08 is 302.3% above this industry median. Based on the distribution chart, Alcon ranks #198 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Alcon has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Alcon ranks #198 out of 852 companies for OCF Yield %. This places Alcon in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.76. Alcon's value of 7.08 is 302.3% above this benchmark. Historically, Alcon's own OCF Yield % has ranged from 0.10 to 7.64 over the past decade. While the company's 10-year median is 3.30 vs. the industry median of 1.76, Alcon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current OCF Yield % of 7.08 is 302.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Alcon and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current OCF Yield % is 7.08, which is 115% above median its own 10-year median of 3.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (MEX:ALC N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,750.95, compared to a current price of MXN1,158.62 — trading 33.8% below its estimated fair value. The current OCF Yield % is 7.08, which is 115% above median its 10-year median of 3.30 and 302.3% above the Medical Devices & Instruments industry median of 1.76. Alcon's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Alcon (MEX:ALC N), the current OCF Yield % is 7.08 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcon (MEX:ALC N) Overvalued in 2026?
Based on GuruFocus' analysis, Alcon stock appears to be undervalued.
The current stock price of MXN1,158.62 is trading 33.8% below its estimated GF Value™ of MXN1,750.95.
GuruFocus considers Alcon to be Significantly Undervalued.
Key valuation signals for MEX:ALC N:
OCF Yield %: 7.08 (115% above median its 10-year median of 3.30)
GF Value™: MXN1,750.95 vs. price of MXN1,158.62 (33.8% below fair value)
Industry Position: 302.3% above the Medical Devices & Instruments median (#198 of 852)
No single metric tells the full story. See the MEX:ALC N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
73GF Score
Get the complete analysis for MEX:ALC N
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ALC N has been successfully added to your 
